SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

2/13/24 11:21:37 AM ET

Professional Services

Consumer Discretionary

Get the next $CCRN alert in real time by email

SC 13G/A 1 cchealthcare2023.txt CROSS COUNTRY HEALTHCARE INC. SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________ SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. ____________) CROSS COUNTRY HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 227483104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) CUSIP NO. 227483104 13G Page 2 of 6 Pages 1. NAMES OF REPORTING PERSONS Systematic Financial Management, L.P. I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) 22-3367558 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* N/A (a) (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Teaneck, New Jersey NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 800,594 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 1,637,674 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,637,674 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9: 4.72% 12. TYPE OF REPORTING PERSON* IA *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 227483104 13G Page 3 of 6 Pages Item 1(a). Name of Issuer: CROSS COUNTRY HEALTHCARE, INC. Item 1(b). Address of Issuer's Principal Executive Offices: 6551 PARK OF COMMERCE, BOULEVARD, N.W. BOCA RATON FL 33487 Item 2(a). Name of Person Filing: Michele Egeberg, Managing Director, Compliance on behalf of SYSTEMATIC FINANCIAL MANAGEMENT, LP Item 2(b). Address of Principal Business Office or, if None, Residence: 300 FRANK W. BURR BLVD., GLENPOINTE EAST, 7TH FLOOR, TEANECK, NJ 07666 Item 2(c). Citizenship: U.S.A. Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 227483104 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act. (b) Bank as defined in Section 3(a)(6) of the Exchange Act. (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) Investment company registered under Section 8 of the Investment Company Act. CUSIP NO. 227483104 13G Page 4 of 6 Pages (e) X An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4. Ownership. (a) Amount beneficially owned: 1,637,674 (b) Percent of class: 4.72% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 800,594 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 1,637,674 (iv) Shared power to dispose or to direct the disposition of 0 CUSIP NO. 227483104 13G Page 5 of 6 Pages Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ X ] Item 6. Ownership of More than Five Percent on Behalf of Another Person N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of Group. N/A Item 10. Certifications. [If filed pursuant to Rule 13d-1(b)]: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. [If filed pursuant to Rule 13d-1(c)]: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP NO. 227483104 13G Page 6 of 6 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2024 (Date) Michele Egeberg, Managing Director, Compliance (Name/Title) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Get the next $CCRN alert in real time by email

Recent Analyst Ratings for

$CCRN

Date	Price Target	Rating	Analyst
3/19/2026	$15.00	Neutral → Outperform	Wedbush
3/5/2026	$14.00	Hold → Buy	The Benchmark Company
2/3/2026	$11.00	Neutral	Wedbush
12/4/2025	$11.00	Mkt Perform → Mkt Outperform	Citizens JMP
12/10/2024		Outperform → Mkt Perform	Barrington Research
12/6/2023		Mkt Perform	JMP Securities
11/3/2023	$32.00 → $21.00	Buy → Hold	Jefferies
6/26/2023		Outperform	William Blair

More analyst ratings

SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

2/13/24 11:21:37 AM ET

$CCRN

Professional Services

Consumer Discretionary

Get the next $CCRN alert in real time by email

Recent Analyst Ratings for

$CCRN

Date	Price Target	Rating	Analyst
3/19/2026	$15.00	Neutral → Outperform	Wedbush
3/5/2026	$14.00	Hold → Buy	The Benchmark Company
2/3/2026	$11.00	Neutral	Wedbush
12/4/2025	$11.00	Mkt Perform → Mkt Outperform	Citizens JMP
12/10/2024		Outperform → Mkt Perform	Barrington Research
12/6/2023		Mkt Perform	JMP Securities
11/3/2023	$32.00 → $21.00	Buy → Hold	Jefferies
6/26/2023		Outperform	William Blair

More analyst ratings

SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$CCRN

SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$CCRN

$CCRN
Analyst Ratings

Cross Country upgraded by Wedbush with a new price target

Cross Country upgraded by The Benchmark Company with a new price target

Wedbush initiated coverage on Cross Country with a new price target

$CCRN
Press Releases

Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution

Cross Country Healthcare Announces First Quarter 2026 Financial Results

Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million

$CCRN
Insider Purchases

Director Cash W Larry bought $40,829 worth of shares (5,000 units at $8.17), increasing direct ownership by 3% to 204,632 units (SEC Form 4)

Director Cash W Larry bought $61,320 worth of shares (6,000 units at $10.22), increasing direct ownership by 3% to 199,632 units (SEC Form 4)

$CCRN
SEC Filings

SEC Form PREM14A filed by Cross Country Healthcare Inc.

SEC Form 10-Q filed by Cross Country Healthcare Inc.

SEC Form DEFA14A filed by Cross Country Healthcare Inc.

$CCRN
Insider Trading

SEC Form 4 filed by Krug Marc S.

SEC Form 4 filed by Hawkins Amiee Lin

SEC Form 4 filed by Clark Kevin Cronin

$CCRN
Leadership Updates

Cross Country Appoints Darrick Sogabe as Chief Product Officer, Advancing the Company's Growing Technology Portfolio

Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy

Cross Country Healthcare Announces CEO Transition

$CCRN
Financials

Cross Country Healthcare Announces First Quarter 2026 Financial Results

Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026

Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

$CCRN
Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.